Gastrointestinal perforations in patients treated with erlotinib: A report of two cases with fatal outcome and literature review
Highlights • Two cases of gastrointestinal perforation (GIP), induced by erlotinib. • Only 1 case of erlotinib-associated GIP under monotherapy reported in the literature. • Risk factors: corticosteroids, medications modifying erlotinib metabolism, diarrhea.
Gespeichert in:
Veröffentlicht in: | Lung cancer (Amsterdam, Netherlands) Netherlands), 2016-09, Vol.99, p.76-78 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights • Two cases of gastrointestinal perforation (GIP), induced by erlotinib. • Only 1 case of erlotinib-associated GIP under monotherapy reported in the literature. • Risk factors: corticosteroids, medications modifying erlotinib metabolism, diarrhea. |
---|---|
ISSN: | 0169-5002 1872-8332 |
DOI: | 10.1016/j.lungcan.2016.06.012 |